Systemic Immunomodulatory Treatments for Atopic Dermatitis

This systematic review with meta-analysis found that compared with dupilumab, abrocitinib, 200 mg daily, and upadacitinib, 30 mg daily, were associated with ...

This living systematic review and network meta-analysis examines the association of systemic treatments for atopic dermatitis with scores on the Eczema Area ...

Systemic Immunomodulatory Treatments for Atopic Dermatitis

In this living systematic review and network meta-analysis, lebrikizumab was similarly effective to dupilumab for the short-term treatment ...

Systemic Immunomodulatory Treatments for Atopic Dermatitis

These findings indicate that lebrikizumab, a new biologic medication, has comparable efficacy to dupilumab for the treatment of atopic dermatitis in adults.

Systemic immunomodulatory treatments for eczema

Biologics are new-ish drugs that target specific parts of the immune system. Dupilumab (Dupixent) is the first biologic approved for treating ...

Systemic immunomodulatory treatments for atopic dermatitis

This protocol describes methods for a systematic review and network meta-analysis of systemic treatments for atopic dermatitis.

Comparing binary efficacy outcomes for systemic ... - Oxford Academic

In previous updates of a living systematic review and network meta-analysis, systemic immunomodulatory medications for atopic dermatitis have been compared.

Systemic treatments for atopic dermatitis (eczema): Systematic ...

High-dose abrocitinib and low-dose upadacitinib are effective, but also among the most harmful. Dupilumab, lebrikizumab, and tralokinumab are of ...

Systemic treatments for atopic dermatitis (eczema): Systematic ...

High-dose abrocitinib and low-dose upadacitinib are effective, but also among the most harmful. Dupilumab, lebrikizumab, and tralokinumab are of intermediate ...

Guidelines of care for the management of atopic dermatitis in adults ...

Cyclosporine, methotrexate, azathioprine, and mycophenolate are the most commonly recommended older systemic therapies for AD. We gave each of ...

Comparison of Old and New Systemic Treatments for Moderate to ...

Historically, systemic treatments for atopic dermatitis (AD) primarily consisted of immunosuppressive agents such as corticosteroids and ...

The effects of systemic immunomodulatory treatments on COVID‐19 ...

Atopic dermatitis (AD, also known as atopic eczema) is a complex chronic inflammatory skin disease. Both genetic and environmental factors play ...

Comparative safety of systemic immunomodulatory medications in ...

The risk of serious infections among users of systemic immunomodulatory medications is not well understood in patients with atopic dermatitis. ... In adults with ...

Systemic Immunomodulatory Treatment for Atopic Dermatitis

We have a number of long-standing oral treatments, and these are all immunosuppressants that have been used for atopic dermatitis. These are ...

Systemic Immunomodulatory Treatments for Patients with Atopic ...

Importance: Most clinical trials assessing systemic immunomodulatory treatments for patients with atopic dermatitis are placebo-controlled. Objective: To ...

Systemic Immunomodulatory Treatments for Atopic Dermatitis

Conclusions and Relevance: In this living systematic review and network meta-analysis, lebrikizumab was similarly effective to dupilumab for the ...

(PDF) Systemic Immunomodulatory Treatments for Atopic Dermatitis

Conclusions Supporting results for continuous measures, upadacitinib 30 mg daily and abrocitinib 200 mg daily are the most efficacious with ...

Safety of systemic immunomodulatory drugs in atopic dermatitis

“Among non-biologic systemic agents, cyclosporine and methotrexate appear to have better safety profiles than mycophenolate, azathioprine and ...

Comparing Systemic Immunomodulatory Treatments for Atopic ...

For atopic dermatitis (AD) treatment, abrocitinib 200 mg and upadacitinib 30 mg were associated with slightly better index scores than ...

Medline ® Abstract for Reference 129 of 'Treatment of atopic ...

IMPORTANCE Most clinical trials assessing systemic immunomodulatory treatments for patients with atopic dermatitis are placebo-controlled. OBJECTIVE To ...